ATE260989T1 - Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen - Google Patents

Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen

Info

Publication number
ATE260989T1
ATE260989T1 AT98964070T AT98964070T ATE260989T1 AT E260989 T1 ATE260989 T1 AT E260989T1 AT 98964070 T AT98964070 T AT 98964070T AT 98964070 T AT98964070 T AT 98964070T AT E260989 T1 ATE260989 T1 AT E260989T1
Authority
AT
Austria
Prior art keywords
insights
search
active ingredients
genome research
novel active
Prior art date
Application number
AT98964070T
Other languages
English (en)
Inventor
David J Lockhart
Lisa Wodicka
Ming Hsui Ho
Original Assignee
Affymetrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affymetrix Inc filed Critical Affymetrix Inc
Application granted granted Critical
Publication of ATE260989T1 publication Critical patent/ATE260989T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98964070T 1997-12-19 1998-12-18 Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen ATE260989T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6828997P 1997-12-19 1997-12-19
PCT/US1998/026925 WO1999032660A1 (en) 1997-12-19 1998-12-18 Exploiting genomics in the search for new drugs

Publications (1)

Publication Number Publication Date
ATE260989T1 true ATE260989T1 (de) 2004-03-15

Family

ID=22081628

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98964070T ATE260989T1 (de) 1997-12-19 1998-12-18 Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen

Country Status (6)

Country Link
US (3) US6333155B1 (de)
EP (1) EP1040204B1 (de)
AT (1) ATE260989T1 (de)
AU (1) AU1926899A (de)
DE (1) DE69822206T2 (de)
WO (1) WO1999032660A1 (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720140B1 (en) 1995-06-07 2004-04-13 Invitrogen Corporation Recombinational cloning using engineered recombination sites
US6143557A (en) 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
US6165709A (en) 1997-02-28 2000-12-26 Fred Hutchinson Cancer Research Center Methods for drug target screening
IL135776A0 (en) * 1997-10-24 2001-05-20 Life Technologies Inc Recombinational cloning using nucleic acids having recombination sites
US20030124555A1 (en) * 2001-05-21 2003-07-03 Invitrogen Corporation Compositions and methods for use in isolation of nucleic acid molecules
US7351578B2 (en) 1999-12-10 2008-04-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
DE60042969D1 (de) 1999-03-02 2009-10-29 Life Technologies Corp Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren
US7244559B2 (en) * 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
EP1283904A2 (de) * 1999-11-03 2003-02-19 Oncotech, Inc. Diagnose von krebs mit zellsortierung und genexpressionsprofilen
JP4729222B2 (ja) * 1999-12-10 2011-07-20 ライフ テクノロジーズ コーポレーション 組換えクローニングにおける独自の選択性を有する複数の組換え部位の使用
US7829313B2 (en) 2000-03-24 2010-11-09 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US8288128B2 (en) 2004-11-18 2012-10-16 Eppendorf Array Technologies S.A. Real-time quantification of multiple targets on a micro-array
AU2001256244A1 (en) * 2000-03-31 2001-10-08 Memorec Stoffel Gmbh - Medizinisch-Molekulare Entwicklung, Koln Use of particles which have signal-emitting characteristics and at least one group with an affinity for marked nucleic acids
US7157227B2 (en) * 2000-03-31 2007-01-02 University Of Louisville Research Foundation Microarrays to screen regulatory genes
US7244560B2 (en) * 2000-05-21 2007-07-17 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US6743583B2 (en) * 2000-07-14 2004-06-01 The Board Of Trustees Of The Leland Stanford Junior University Identification of drugs and drug targets by detection of the stress response
EP1301632A2 (de) * 2000-07-19 2003-04-16 Pointilliste, Inc. Eingebettetes sortieren und hochdurchsatzscreening
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US6998234B2 (en) * 2000-11-03 2006-02-14 Oncotech, Inc. Methods for cancer prognosis and diagnosis relating to tumor vascular endothelial cells
WO2002095000A2 (en) 2001-05-22 2002-11-28 Gene Logic, Inc. Molecular toxicology modeling
US20050009022A1 (en) * 2001-07-06 2005-01-13 Weiner Michael P. Method for isolation of independent, parallel chemical micro-reactions using a porous filter
US7447594B2 (en) 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
US20030054396A1 (en) * 2001-09-07 2003-03-20 Weiner Michael P. Enzymatic light amplification
US6956114B2 (en) 2001-10-30 2005-10-18 '454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US6902921B2 (en) 2001-10-30 2005-06-07 454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US20050124022A1 (en) * 2001-10-30 2005-06-09 Maithreyan Srinivasan Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
CA2472030A1 (en) * 2002-01-24 2003-07-31 Pointilliste, Inc. Use of collections of binding sites for sample profiling and other applications
US20030195431A1 (en) * 2002-04-10 2003-10-16 Sukhatme Vikas P. Observation of effects of body fluids on indicator cells for disease diagnosis
US20040053319A1 (en) * 2002-09-17 2004-03-18 Mcwilliams Diana R. Isolation of genetic molecules from a complex biological constrauct for use in genetic expression analysis
US7364846B2 (en) * 2002-10-11 2008-04-29 Molecular Devices Corporation Gene expression profiling from FFPE samples
US7781163B2 (en) * 2003-01-08 2010-08-24 Lesley Davenport G-quadruplex binding assays and compounds therefor
US7575865B2 (en) 2003-01-29 2009-08-18 454 Life Sciences Corporation Methods of amplifying and sequencing nucleic acids
JP4480715B2 (ja) 2003-01-29 2010-06-16 ４５４ コーポレーション 二重末端シーケンシング
WO2004079000A1 (en) * 2003-03-07 2004-09-16 National Research Council Of Canada The determination of function of mammalian proteins by analysis of global gene expression profiles
US20070105101A1 (en) 2003-04-14 2007-05-10 Mira Susa Spring Gene expression associated with osteobla st differentiation
US20050009059A1 (en) * 2003-05-07 2005-01-13 Affymetrix, Inc. Analysis of methylation status using oligonucleotide arrays
CN1871352A (zh) 2003-06-06 2006-11-29 阿博根有限公司 调节植物细胞多醣的组合物和方法
EP1639089A4 (de) 2003-06-06 2007-12-12 Arborgen Llc Transkriptionsfaktor
US20050064462A1 (en) * 2003-06-17 2005-03-24 Bernd Stein Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms
US20050064472A1 (en) * 2003-07-23 2005-03-24 Affymetrix, Inc. Methods of monitoring gene expression
EP3246093A1 (de) 2003-10-24 2017-11-22 Aushon Biosystems, Inc. Vorrichtung und verfahren zur ausgabe von flüssigen, halbflüssigen und festen proben
WO2005054438A2 (en) 2003-12-01 2005-06-16 Invitrogen Corporation Nucleic acid molecules containing recombination sites and methods of using the same
AR047574A1 (es) 2003-12-30 2006-01-25 Arborgen Llc 2 Genesis Res 1 Genes del ciclo celular y metodos de uso relacionados
US7598080B2 (en) 2004-08-20 2009-10-06 Carl Deirmengian Diagnostic assay for source of inflammation
FI20041204A0 (fi) 2004-09-16 2004-09-16 Riikka Lund Menetelmät immuunivälitteisiin sairauksiin liittyvien uusien kohdegeenien hyödyntämiseksi
US7799906B1 (en) 2004-09-22 2010-09-21 Arborgen, Llc Compositions and methods for modulating lignin of a plant
ATE482288T1 (de) 2004-11-18 2010-10-15 Eppendorf Array Technologies Echtzeit-pcr von zielen auf einem mikroarray
CA2601922C (en) 2005-02-18 2020-11-24 Monogram Biosciences, Inc. Methods and compositions for determining anti-hiv drug susceptibility and replication capacity of hiv
WO2006089045A2 (en) 2005-02-18 2006-08-24 Monogram Biosciences, Inc. Methods and compositions for determining hypersusceptibility of hiv-1 to non-nucleoside reverse transcriptase inhibitors
US20070072175A1 (en) * 2005-05-13 2007-03-29 Biogen Idec Ma Inc. Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
WO2006130477A2 (en) 2005-05-27 2006-12-07 Monogram Biosciences, Inc. Methods and compositions for determining resistance of hiv-1 to protease inhibitors
US8071284B2 (en) 2005-06-06 2011-12-06 Monogram Biosciences, Inc. Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs
WO2006133266A2 (en) 2005-06-06 2006-12-14 Monogram Biosciences, Inc. Methods for determining resistance or susceptibility to hiv entry inhibitors
EP1736780A1 (de) 2005-06-24 2006-12-27 Eppendorf Array Technologies S.A. Verfahren und Vorrichtungen zum Nachweis und/oder zur Quantifizierung hierarchischer, molekularer Veränderungen einer Zellantwort auf einen externen Stimulus
CA2620528A1 (en) * 2005-09-02 2007-03-08 The University Of Toledo Methods and compositions for identifying biomarkers useful in diagnosis and/or treatment of biological states
EP1762628B1 (de) 2005-09-13 2008-03-12 Eppendorf Array Technologies SA Verfahren zum Nachweis von homologen Sequenzen, welche sich durch eine Base unterscheiden, auf einem Mikroarray
US20070092903A1 (en) * 2005-10-24 2007-04-26 Fulmer-Smentek Stephanie B One-color microarray analysis methods, reagents and kits
AU2005239672B2 (en) * 2005-11-30 2009-06-11 Canon Kabushiki Kaisha Sortable collection browser
WO2007098065A2 (en) * 2006-02-17 2007-08-30 The United States Of America As Represented By The Department Of Veterans Affairs Human sodium channel isoforms
US20100070186A1 (en) * 2006-03-15 2010-03-18 Soper Bryan R Methods of screening for and mapping phenotypic and genotypic variations in cells
US7901882B2 (en) 2006-03-31 2011-03-08 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
US8257929B2 (en) 2006-10-20 2012-09-04 University Of Miami Gene expression profiling of Parkinson's Disease
EP1935496A1 (de) 2006-12-22 2008-06-25 Eppendorf Array Technologies SA Vorrichtung und/oder Verfahren zur Detektion erweiterter Nukleotidsequenzen auf Mikro-Arrays
EP1961825A1 (de) 2007-02-26 2008-08-27 INSERM (Institut National de la Santé et de la Recherche Medicale) Verfahren zur Vorhersage des Auftretens von Metastasen bei Brustkrebspatienten
US9581595B2 (en) 2007-02-26 2017-02-28 Laboratory Corporation Of America Holdings Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy
EP2107125A1 (de) 2008-03-31 2009-10-07 Eppendorf Array Technologies SA (EAT) Echtzeit-PCR von Targets auf einem Mikroarray
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US20110190662A1 (en) * 2008-10-01 2011-08-04 Beacon Endoscopic Corporation Rapid exchange fna biopsy device with diagnostic and therapeutic capabilities
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
JP2013515500A (ja) 2009-12-29 2013-05-09 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 炎症性の病気の改善または予防のための、ショウガが含まれる組成物
FI20105166A0 (fi) 2010-02-19 2010-02-19 Suomen Punainen Risti Veripalv Menetelmä kantasolupopulaation erilaistumistilan osoittamiseksi
EP2369325A1 (de) 2010-03-12 2011-09-28 Eppendorf Ag Arrayanalyse für Online-Detektion
US9453261B2 (en) 2011-09-20 2016-09-27 The George Washington University Alternative splicing variants of genes associated with prostate cancer risk and survival
US9988687B2 (en) 2011-09-20 2018-06-05 The George Washington Univeristy Companion diagnostics for cancer and screening methods to identify companion diagnostics for cancer based on splicing variants
EP3418397B1 (de) 2012-01-24 2020-10-07 CD Diagnostics, Inc. System zum nachweis einer infektion in der synovialflüssigkeit
EP2664619B1 (de) * 2012-05-16 2017-07-12 Manros Therapeutics Purinderivate als Werkzeuge zum Abtasten von Verbindungen gegen Alzheimer
US9671405B2 (en) 2012-09-19 2017-06-06 Cornell University Identifying taxane sensitivity in prostate cancer patients
EP3736570A1 (de) 2019-05-09 2020-11-11 Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León Verfahren zur diagnose, subklassifizierung und prognose von akuter nierenverletzung durch detektion von cct7

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
JP3488465B2 (ja) * 1993-10-28 2004-01-19 ヒューストン・アドバンスド・リサーチ・センター 結合反応を別々に検出する微細加工フロースルー多孔性装置
AU2253397A (en) * 1996-01-23 1997-08-20 Affymetrix, Inc. Nucleic acid analysis techniques
WO1997029091A1 (en) 1996-02-09 1997-08-14 Phytera Symbion Aps Balanol analogues
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
US5965352A (en) 1998-05-08 1999-10-12 Rosetta Inpharmatics, Inc. Methods for identifying pathways of drug action

Also Published As

Publication number Publication date
US6524800B2 (en) 2003-02-25
US20010055771A1 (en) 2001-12-27
US6333155B1 (en) 2001-12-25
EP1040204A1 (de) 2000-10-04
AU1926899A (en) 1999-07-12
DE69822206D1 (de) 2004-04-08
WO1999032660A1 (en) 1999-07-01
DE69822206T2 (de) 2005-02-17
US20030180774A1 (en) 2003-09-25
WO1999032660A9 (en) 1999-09-23
EP1040204B1 (de) 2004-03-03

Similar Documents

Publication Publication Date Title
ATE260989T1 (de) Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen
Roth et al. An amino acid as a cofactor for a catalytic polynucleotide
SG147468A1 (en) High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences
DE69927046D1 (de) Vektoren für die gen-mutagenese und die entdeckung von genen durch 'gene-trapping'
MX9703063A (es) Compuestos de ester y acido boronico, su sintesis y usos.
MX9800499A (es) Inhibicion de la expresion de genes.
DE3881941T2 (de) Elektrodensubstrat für Brennstoffzelle und Verfahren zu seiner Herstellung.
IL180924A (en) Method for regulating cell proliferation and cell death
BR8506273A (pt) Gene de glicoamilase,vetor compreendendo o mesmo,microorganismo transformado,e processo para produzir glicoamilase
DE69433626D1 (de) N-2 substituierte purine
TR200002446T2 (tr) Fosfolipaz enzimlerinin inhibitörleri
ES2195993T3 (es) Metodo para inhibir la produccion de etileno en plantas.
ATE213019T1 (de) Chimäre oligomere mit einer rns- spaltungsaktivität
DE69939056D1 (de) Vektoren für genmutagenese und genentdeckung
DK0610474T3 (da) Dyrecellekultur
DE50015772D1 (de) Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen
MX9800500A (es) Inhibicion de la expresion de genes.
NZ538852A (en) Selection and isolation of living cells using mRNA-binding probes
DK1141358T3 (da) Stabilt transfekterede celler til identificering af forbindelser, der påvirker stabiliteten af mRNA
DE69805627T2 (de) Verbesserte stämme für die protein-expression
KR870700096A (ko) 유용한 메탈로프로테이나제 억제제 씨퀀스 재결합 보균자계와 그의 제조를 위한 dna 재결합방법
TR200000140T2 (tr) Endojenik gen etkinliği ile insan proteini üretimi için insan hücre sıralarının belirlenmesi
NO974367L (no) Vektorer samt fremgangsmåter for gen-ekspresjon i pattedyrceller
ATE275267T1 (de) Verfahren zur parallelen bestimmung der zellvitalität und gentransfer-effizienz
Shugart et al. Poly (ADP-ribosylation) in N, N-diethylnitrosamine-treated mice.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties